BPA Call 36C24820A0022-36C24820N0592
Award Date 5/20/20
Potential Completion Date 5/25/20
Potential Value $136K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gainesville, FL 32608, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a $117,050.64 potential value blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB). The BPA, described as a VISN WIDE BPA with no set-aside designation, is for the delivery of pharmaceutical products and has a completion date of August 20, 2020. Performance will take place in King of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a Blanket Purchase Agreement (BPA) Call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB) for an estimated $136,409.05. The BPA Call has a completion date of October 24, 2020 and was awarded on August 20, 2020 under firm fixed pricing terms. Place of performance will be in King of Prussia, Pennsylvania. No set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded CSL Behring L.L.C. a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The BPA call has a potential value of $25,213.77 and requires delivery of unspecified pharmaceutical or drug products to locations in King of Prussia, Pennsylvania under firm fixed price terms by April 30, 2020. No set-aside designation...
- CSL Behring L.L.C. was awarded a blanket purchase agreement (BPA) call contract valued at one hundred seventeen thousand fifty dollars and sixty-four cents ($117,050.64) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract was awarded on December 22, 2020 under the Pharmaceuticals and Drugs Federal Supply Schedule with a completion date of December 31, 2020. It utilizes firm fixed pricing and has no set-aside designation. The...
- CSL Behring L.L.C. was awarded a blanket purchase agreement (BPA) call against the General Services Administration (GSA) Federal Supply Schedule for Pharmaceuticals and Drugs by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The BPA has a potential value of $66,886.08 and covers the purchase of pharmaceutical products through September 30, 2024 to support VISN 8's healthcare programs. Performance will take place in King of Prussia,...
- CSL Behring L.L.C. was awarded a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The BPA call is for the purchase of Privigen across VISN 8 facilities located in Gainesville, Florida, and has a potential value of $136,441.88 to be paid on a firm fixed price basis. No set-aside designation was applied to this contract award. The BPA was...
- This federal contract award was issued by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The $87,734.72 firm fixed-price delivery order is for the provision of blood clotting medication to VA medical facilities. The contract is not set aside and is issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for...
- This federal contract award is for the procurement of various specialty pharmaceutical products by the U.S. Department of Veterans Affairs (VA) from CSL Behring L.L.C., a global biotherapeutics company. The award, valued at $99,203.50, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The products being delivered include CARIMUNE (immune globulin), PRIVIGEN (immune globulin), and THROMBIN,...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $85,116.00, is for the provision of PLASMA VIALS on a firm fixed price basis. The contract was awarded under the VA's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $113,204 firm fixed price Blanket Purchase Agreement (BPA) Call was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration (GSA) and VA. The contract provides for the delivery of various doses of immune globulin...